VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5525AA: VAERS reports

23 VAERS reports list lot U5525AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2016-07-29 and 2019-07-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
13%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1120%
Injection-site / Local reaction1019%
Musculoskeletal815%
Dermatological (non-injection-site)815%
Respiratory611%
Allergic / Anaphylactic59%
Cardiac / Cardiovascular47%
Neurological12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
Ohio2
Florida2
Kansas2
Utah1
Georgia1
Illinois1
Wisconsin1
Maryland1
Massachusetts1
West Virginia1
New Jersey1

Reports by month received

2016-071
2016-093
2016-102
2016-111
2017-011
2017-021
2017-041
2017-061
2017-072
2017-101
2017-111
2018-031
2019-012
2019-023
2019-041
2019-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.